These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
293 related articles for article (PubMed ID: 23091501)
41. Paving the Way to Personalized Genomic Medicine: Steps to Successful Implementation. Fackler JL; McGuire AL Curr Pharmacogenomics Person Med; 2009 Jun; 7(2):125. PubMed ID: 20098629 [TBL] [Abstract][Full Text] [Related]
42. Prospects of personalized medicine in cardiovascular diseases. Lenfant C Metabolism; 2013 Jan; 62 Suppl 1():S6-10. PubMed ID: 22999711 [TBL] [Abstract][Full Text] [Related]
43. Personalized Management of Cardiovascular Disorders. Jain KK Med Princ Pract; 2017; 26(5):399-414. PubMed ID: 28898880 [TBL] [Abstract][Full Text] [Related]
44. Decision Making on Medical Innovations in a Changing Health Care Environment: Insights from Accountable Care Organizations and Payers on Personalized Medicine and Other Technologies. Trosman JR; Weldon CB; Douglas MP; Deverka PA; Watkins JB; Phillips KA Value Health; 2017 Jan; 20(1):40-46. PubMed ID: 28212967 [TBL] [Abstract][Full Text] [Related]
45. Pharmacogenomics in the treatment of mood disorders: Strategies and Opportunities for personalized psychiatry. Amare AT; Schubert KO; Baune BT EPMA J; 2017 Sep; 8(3):211-227. PubMed ID: 29021832 [TBL] [Abstract][Full Text] [Related]
46. Cardiovascular pharmacogenetics: a promise for genomically-guided therapy and personalized medicine. Zaiou M; El Amri H Clin Genet; 2017 Mar; 91(3):355-370. PubMed ID: 27714756 [TBL] [Abstract][Full Text] [Related]
47. Is personalized medicine a dream or a reality? Morse BL; Kim RB Crit Rev Clin Lab Sci; 2015 Feb; 52(1):1-11. PubMed ID: 25181036 [TBL] [Abstract][Full Text] [Related]
49. Innovative payer engagement strategies: will the convergence lead to better value creation in personalized medicine? Akhmetov I; Bubnov RV EPMA J; 2017 Dec; 8(1):5-15. PubMed ID: 28228864 [TBL] [Abstract][Full Text] [Related]
50. The Promise of Nanotechnology in Personalized Medicine. Alghamdi MA; Fallica AN; Virzì N; Kesharwani P; Pittalà V; Greish K J Pers Med; 2022 Apr; 12(5):. PubMed ID: 35629095 [TBL] [Abstract][Full Text] [Related]
51. Overview of personalized medicine in the disease genomic era. Hong KW; Oh B BMB Rep; 2010 Oct; 43(10):643-8. PubMed ID: 21034525 [TBL] [Abstract][Full Text] [Related]
52. Personalized medicine and allergen immunotherapy: the beginning of a new era? Incorvaia C; Ridolo E; Bagnasco D; Scurati S; Canonica GW Clin Mol Allergy; 2021 Jul; 19(1):10. PubMed ID: 34233706 [TBL] [Abstract][Full Text] [Related]
53. Personalized medicine in Europe: not yet personal enough? Di Paolo A; Sarkozy F; Ryll B; Siebert U BMC Health Serv Res; 2017 Apr; 17(1):289. PubMed ID: 28424057 [TBL] [Abstract][Full Text] [Related]
54. The future of healthcare--information based medicine. Borangíu T; Purcarea V J Med Life; 2008; 1(2):233-7. PubMed ID: 20108471 [TBL] [Abstract][Full Text] [Related]
55. Policy perspectives on the emerging pathways of personalized medicine. Downing GJ Dialogues Clin Neurosci; 2009; 11(4):377-87. PubMed ID: 20135895 [TBL] [Abstract][Full Text] [Related]
56. Challenges and opportunities in cardiovascular health informatics. Zhang YT; Zheng YL; Lin WH; Zhang HY; Zhou XL IEEE Trans Biomed Eng; 2013 Mar; 60(3):633-42. PubMed ID: 23380853 [TBL] [Abstract][Full Text] [Related]
58. Personalized medicine: how much can we afford? A bioethics perspective. Lunshof J Per Med; 2005 Mar; 2(1):43-47. PubMed ID: 29793239 [TBL] [Abstract][Full Text] [Related]
59. Personalized Medicine in a New Genomic Era: Ethical and Legal Aspects. Shoaib M; Rameez MAM; Hussain SA; Madadin M; Menezes RG Sci Eng Ethics; 2017 Aug; 23(4):1207-1212. PubMed ID: 27896605 [TBL] [Abstract][Full Text] [Related]